Related Experiment Video
Updated: Aug 8, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Successful lamivudine therapy for chronic hepatitis B in the family]
1Vojnomedicinska akademija, Klinika za infektivne i tropske bolesti, Beograd, Srbija i Crna Gora. darkonozic@yahoo.com
Background:
Hepatitis B virus infection is a global public health problem since it is a leading cause of liver cirrhosis and hepatocellular carcinoma. An optimal treatment is needed to reduce mortality. Current therapies for chronic hepatitis B include standard and pegilated interferon-alfa and nucleoside and nucleotide analogies, primarily lamivudine and adefovir. Each of the therapies, however has various limitations.
Case Report:
In this paper we presented a father and his daughter with chronic hepatitis B, successfully treated with lamivudine.
Conclusion:
In the linked cases of chronic hepatitis B, the choice of antiviral medicine in some patients could also be made on the basis of its efficacy in the persons previously treated with it, even without determining virus genotype.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Antiviral Nucleoside Inhibitors
Retrovirus Life Cycles
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Inhibitors of Viral Protein Synthesis
